SirturoActive Ingredient(s): Bedaquiline
FDA Approved: * December 28, 2012
Pharm Company: * JANSSEN R AND D
Bedaquiline, sold under the brand name Sirturo, is a medication used to treat active tuberculosis. Specifically, it is used to treat multi-drug-resistant tuberculosis (MDR-TB) along with other medications for tuberculosis. It is used by mouth. Common side effects include nausea, joint pains, headaches, and chest pain. Serious side effects include QT prolongation, liver dysfunction... [wikipedia]* May have multiple approval dates, manufacturers, or labelers.